Literature DB >> 26742901

Effects of omega-3 polyunsaturated fatty acids on human brain morphology and function: What is the evidence?

Dienke J Bos1, Simone J T van Montfort2, Bob Oranje2, Sarah Durston2, Paul A M Smeets3.   

Abstract

Public opinion and media coverage suggest that there are benefits of long-chain ω-3 polyunsaturated fatty acid (LC-PUFA) intake on brain functioning. However, it is an open question whether this is indeed the case. Therefore, we reviewed the evidence for effects of ω-3 LC-PUFA on human brain morphology and function. We included studies on (1) naturalistic long-term ω-3 LC-PUFA intake during life (2) the effects of short-term ω-3 LC-PUFA supplementation in healthy subjects and (3) the effects of ω-3 LC-PUFA supplementation as alternative or add-on treatment for psychiatric or neurological disorders. To date, 24 studies have been published on the effect of ω-3 LC-PUFA on brain function and structure. Findings from naturalistic studies and clinical trials in healthy individuals indicate that ω-3 LC-PUFA intake may be associated with increased functional activation of the prefrontal cortex in children, and greater gray matter volume and white matter integrity during aging. However, most naturalistic studies were cross-sectional or did not find any effect on cognition. As such, it is hard to estimate the magnitude of any beneficial effects. Furthermore, there is only limited evidence to support that ω-3 LC-PUFA supplementation is beneficial in brain disorders, such as Alzheimer's Disease, Attention Deficit/Hyperactivity Disorder, Major Depressive Disorder and schizophrenia. Overall, the literature suggests that sensitivity to supplementation may vary over development, and as a consequence of brain disorders. The biological mechanisms underlying any (beneficial) effects ω-3 LC-PUFAs on the brain are currently unknown and need to be investigated.
Copyright © 2016 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Brain function; Brain morphology; DHA; Development; EPA; Omega-3

Mesh:

Substances:

Year:  2015        PMID: 26742901     DOI: 10.1016/j.euroneuro.2015.12.031

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  28 in total

1.  Erythrocyte omega-3 index, ambient fine particle exposure, and brain aging.

Authors:  Cheng Chen; Pengcheng Xun; Joel D Kaufman; Kathleen M Hayden; Mark A Espeland; Eric A Whitsel; Marc L Serre; William Vizuete; Tonya Orchard; William S Harris; Xinhui Wang; Helena C Chui; Jiu-Chiuan Chen; Ka He
Journal:  Neurology       Date:  2020-07-15       Impact factor: 9.910

2.  Long-chain polyunsaturated fatty acid supplementation in the first year of life affects brain function, structure, and metabolism at age nine years.

Authors:  Rebecca J Lepping; Robyn A Honea; Laura E Martin; Ke Liao; In-Young Choi; Phil Lee; Vlad B Papa; William M Brooks; D Jill Shaddy; Susan E Carlson; John Colombo; Kathleen M Gustafson
Journal:  Dev Psychobiol       Date:  2018-10-11       Impact factor: 3.038

3.  Nutrient biomarkers shape individual differences in functional brain connectivity: Evidence from omega-3 PUFAs.

Authors:  Tanveer Talukdar; Marta K Zamroziewicz; Christopher E Zwilling; Aron K Barbey
Journal:  Hum Brain Mapp       Date:  2018-12-16       Impact factor: 5.038

Review 4.  Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders.

Authors:  R J T Mocking; J Assies; H G Ruhé; A H Schene
Journal:  J Inherit Metab Dis       Date:  2018-03-09       Impact factor: 4.982

5.  Omega-3 Supplementation and the Neural Correlates of Negative Affect and Impulsivity: A Double-Blind, Randomized, Placebo-Controlled Trial in Midlife Adults.

Authors:  Annie T Ginty; Matthew F Muldoon; Dora C H Kuan; Brittney Schirda; Thomas W Kamarck; J Richard Jennings; Stephen B Manuck; Peter J Gianaros
Journal:  Psychosom Med       Date:  2017-06       Impact factor: 4.312

6.  Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study.

Authors:  Licinia Ganança; Hanga C Galfalvy; Maria A Oquendo; Adrienne Hezghia; Thomas B Cooper; J John Mann; M Elizabeth Sublette
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-03-10       Impact factor: 4.006

7.  Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.

Authors:  Annelies A J Verlaet; Annelies Breynaert; Berten Ceulemans; Tess De Bruyne; Erik Fransen; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-22       Impact factor: 4.785

8.  A Combination of Essential Fatty Acids, Panax Ginseng Extract, and Green Tea Catechins Modifies Brain fMRI Signals in Healthy Older Adults.

Authors:  O T Carmichael; S Pillai; P Shankapal; A McLellan; D G Kay; B T Gold; J N Keller
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

9.  A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.

Authors:  Catherine Cornu; Catherine Mercier; Tiphanie Ginhoux; Sandrine Masson; Julie Mouchet; Patrice Nony; Behrouz Kassai; Valérie Laudy; Patrick Berquin; Nathalie Franc; Marie-France Le Heuzey; Hugues Desombre; Olivier Revol
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

10.  The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: a randomized clinical trial.

Authors:  Regina L Leckie; David E Lehman; Peter J Gianaros; Kirk I Erickson; Susan M Sereika; Dora C H Kuan; Stephen B Manuck; Christopher M Ryan; Jeffrey K Yao; Matthew F Muldoon
Journal:  Psychol Med       Date:  2019-10-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.